01
Beschaffung
In auditierten Anlagen synthetisierte Verbindungen. Identität jeder Charge mittels Massenspektrometrie bestätigt.
Präzision.
Konsistenz.
Vertrauen.
Von Drittlaboren getestet
≥99 % HPLC-Reinheit
Kühlkettenversand
Weltweite Lieferung
Eine kuratierte Auswahl forschungsorientierter Formate in Ampullen, Injektionspens und Nasensprays.
BPC 157 10mg
10mg
Investigated in preclinical studies for its potential role in tissue regeneration, gastrointestinal mucosal repair, and modulation of inflammatory pathways.
For research use only
TB500 10mg
10mg
Synthetic analogue of Thymosin Beta-4 studied in preclinical models for its potential involvement in wound healing mechanisms, skeletal muscle repair, and the downregulation of pro-inflammatory cytokines.
For research use only
GHK-Cu 50mg
50 mg
Naturally occurring copper-binding tripeptide investigated in preclinical research for its potential role in extracellular matrix remodeling, collagen and elastin synthesis, and cutaneous tissue regeneration.
For research use only
GHK-CU 100 mg
100 mg
Naturally occurring copper-binding tripeptide investigated in preclinical research for its potential role in extracellular matrix remodeling, collagen and elastin synthesis, and cutaneous tissue regeneration.
For research use only
TESAMORELIN 10 mg
10mg
ynthetic analogue of growth hormone-releasing hormone (GHRH) studied in research settings for its potential role in growth hormone secretion pathways and the modulation of visceral adipose tissue metabolism.
For research use only
MOTS-C 10mg
10mg
Mitochondria-derived peptide investigated in preclinical studies for its potential role in mitochondrial energy regulation, metabolic homeostasis, and insulin signaling pathways.
For research use only
MOTS-C 20 mg
20 mg
Mitochondria-derived peptide investigated in preclinical studies for its potential role in mitochondrial energy regulation, metabolic homeostasis, and insulin signaling pathways.
For research use only
RETATRUTID 10mg
10mg
Triple receptor agonist targeting GLP-1, GIP, and glucagon receptors, investigated in research settings for its potential role in energy expenditure regulation, adipose tissue reduction, and metabolic pathway modulation.
For research use only
RETATRUTID 15mg
15 mg
Triple receptor agonist targeting GLP-1, GIP, and glucagon receptors, investigated in research settings for its potential role in energy expenditure regulation, adipose tissue reduction, and metabolic pathway modulation.
For research use only
RETATRUTIDE 20 mg
20 mg
Triple receptor agonist targeting GLP-1, GIP, and glucagon receptors, investigated in research settings for its potential role in energy expenditure regulation, adipose tissue reduction, and metabolic pathway modulation.
For research use only
CJC1295 NO DAC+IPA 10mg
10mg (5+5)
Commonly investigated together in preclinical research for their potential synergistic role in pulsatile growth hormone release and somatotropic axis modulation.
For research use only
GLOW 70mg (50+10+10)
70 mg
Proprietary research blend combining BPC-157, TB-500, and GHK-Cu, investigated in preclinical settings for their potential synergistic role in extracellular matrix remodeling, collagen biosynthesis, tissue regeneration, and oxidative stress modulation in cutaneous tissue.
For research use only
BPC 157 10mg
10mg
Investigated in preclinical studies for its potential role in tissue regeneration, gastrointestinal mucosal repair, and modulation of inflammatory pathways.
For research use only
RETATRUTID 15mg
15 mg
Triple receptor agonist targeting GLP-1, GIP, and glucagon receptors, investigated in research settings for its potential role in energy expenditure regulation, adipose tissue reduction, and metabolic pathway modulation.
For research use only
SEMAX 22,5mg
20 mg
Investigated in preclinical research for its potential role in cognitive function modulation, neurotrophic factor expression, and neuroprotective mechanisms.
For research use only
NAD+ 300mg
300 mg
Studied in preclinical research for its potential role in cellular energy metabolism, mitochondrial function, and DNA repair pathway modulation.
For research use only
BAKTERIOSTATISCHES WASSER 10 ml
10 ml
For research use only
Wissenschaft
01
In auditierten Anlagen synthetisierte Verbindungen. Identität jeder Charge mittels Massenspektrometrie bestätigt.
02
Unabhängige HPLC für Reinheit und Konzentration. Datierte, chargenbezogene, öffentlich zugängliche Berichte.
03
Stabile Standards in Formulierung, Lagerung, Verpackung und Kundenservice – darauf ausgelegt, über die Zeit hinweg das gleiche Qualitätsniveau zu liefern.
Forschungsnotizen
GHK-Cu ist ein kupferbindendes Tripeptid, das auf natürliche Weise vom Körper produziert wird – und eines der am besten untersuchten Peptide überhaupt. Dieser Artikel beleuchtet 50 Jahre Forschung zu Gewebereparatur, Kollagensynthese, Genexpression und Anti-Aging-Anwendungen.
Mehr erfahren →
Semaglutid und Tirzepatid sind nicht aus dem Nichts gekommen. Sie nutzen drei Darmpeptide – GLP-1, GIP und Glukagon –, die seit Millionen von Jahren den menschlichen Hunger und Stoffwechsel regulieren. So steuert diese Peptid-Dreifaltigkeit tatsächlich Appetit, Energiespeicherung und die nächste Generation der Stoffwechselmedizin.
Mehr erfahren →
Warum kann man ein Peptid nicht einfach schlucken? Der Darm ist außergewöhnlich gut darin, genau die Art von Molekülen zu zerstören, die die besten Medikamente abgeben. Hier erfahren Sie, wie Magensäure, Proteasen und die Darmwand fast jedes Peptid besiegen – und wie die Wissenschaft endlich beginnt, den Kampf um die orale Verabreichung zu gewinnen.
Mehr erfahren →